Welcome to our dedicated page for BlackRock ESG Capital Allocation Term Trust SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock ESG Capital Allocation Term Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock ESG Capital Allocation Term Trust's regulatory disclosures and financial reporting.
Saba Capital Management, L.P. reported a sale of 5,776 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) on 09/16/2025 at $16.51 per share. After the transaction the filer reports beneficial ownership of 27,849,571 shares held indirectly. The Form 4 is signed by representatives Zachary Gindes and Boaz Weinstein on 09/17/2025, and the filing indicates the reporting person is a director and a 10% owner.
Saba Capital Management, L.P. reported sales of common stock in BlackRock ESG Capital Allocation Term Trust (ECAT). The filing shows two transactions: on 09/11/2025 Saba sold 4,006 shares at $16.76, and on 09/12/2025 it sold 19,682 shares at $16.79, totaling 23,688 shares sold. After the transactions, Saba held 27,855,347 shares beneficially. The ownership is reported as indirect, and the reporting relationship checked indicates Director and 10% owner status. No derivative securities were reported. The form is signed by Zachary Gindes and Boaz Weinstein on 09/15/2025.
Saba Capital Management, L.P. and individual reporting person Boaz Weinstein filed a Form 4 disclosing sales of common stock of BlackRock ESG Capital Allocation Term Trust (ECAT). On 09/09/2025 they reported a sale of 76,416 shares at $16.69 and on 09/10/2025 a sale of 109,895 shares at $16.70. Following those sales the reporting entities beneficially owned 27,988,930 and 27,879,035 shares, respectively. The form is signed and dated 09/11/2025.
Saba Capital Management, L.P. and reporting person Boaz Weinstein disclosed a sale of common stock of BlackRock ESG Capital Allocation Term Trust (ECAT). On 09/08/2025 they sold 79,152 shares at $16.66 per share. After the transaction they report beneficial ownership of 28,065,346 shares, held indirectly. The filing lists the reporters as a director and a 10% owner.
Form 4 shows Saba Capital Management and Boaz Weinstein reported sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock. The filing lists two dispositions: 91,395 shares sold at $16.55 and 67,373 shares sold at $16.56, leaving an indirect beneficial ownership of 28,144,498 shares after the second sale. Both reporting persons are identified as directors and 10% owners.
Form 4 disclosure: Saba Capital Management, L.P. and Boaz Weinstein reported sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock on 09/02/2025 and 09/03/2025. The filings show dispositions of 130,848 shares at $16.38 and 89,882 shares at $16.50, respectively. After these transactions, the reporting persons beneficially owned 28,303,266 shares (indirect).
Form 4 summary: Saba Capital Management, L.P. and Boaz Weinstein reported insider sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock. On 08/28/2025 they sold 4,397 shares at $16.63 and on 08/29/2025 they sold 76,648 shares at $16.51. Beneficial ownership declined from 28,600,644 shares to 28,523,996 shares; ownership is reported indirect. The filing is signed by Saba and Boaz Weinstein.
BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) filed DEFA14A materials highlighting decisive support from all three major proxy advisory firms—ISS, Glass Lewis and Egan-Jones. Each adviser urges shareholders to use the WHITE proxy card to re-elect the Fund’s ten incumbent trustees and vote against a dissident proposal from Saba Capital to terminate BlackRock Advisors, LLC as investment adviser. Egan-Jones cites ECAT’s “superior” shareholder returns versus peers and says Saba “has not made a compelling case” for termination, warning that such action would be “detrimental to the Fund’s future state.” The Annual Meeting is scheduled for 26 June 2025. Shareholders who have already submitted the dissident’s gold card may change their vote via the methods listed on the WHITE card. Proxy solicitation questions are directed to Georgeson LLC at (866) 441-6128.
BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) has released Definitive Additional Materials (Form DEFA14A) ahead of its 2025 annual meeting.
- Proposal 1: Election of ten director nominees across Class I, II and III seats; the fund’s board recommends a vote "FOR" all nominees.
- Proposal 2: A hedge-fund-backed motion from Saba Capital Management to terminate the current investment-management agreement with BlackRock Advisors, LLC; the board recommends voting "AGAINST" this proposal.
The filing states that no SEC filing fee was required. Shareholders are urged to use the WHITE proxy card and may vote online, by phone or by mail. Failure to vote could lead to significant changes in management and distribution policy.